Mikael Dolsten - Net Worth and Insider Trading
Mikael Dolsten Net Worth
The estimated net worth of Mikael Dolsten is at least $9 Million dollars as of 2024-04-27. Mikael Dolsten is the President R&D of Pfizer Inc and owns about 335,159 shares of Pfizer Inc (PFE) stock worth over $9 Million. Details can be seen in Mikael Dolsten's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mikael Dolsten has not made any transactions after 2022-05-11 and currently still holds the listed stock(s).
Transaction Summary of Mikael Dolsten
Mikael Dolsten Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mikael Dolsten owns 3 companies in total, including Karyopharm Therapeutics Inc (KPTI) , Pfizer Inc (PFE) , and Agilent Technologies Inc (A) .
Click here to see the complete history of Mikael Dolsten’s form 4 insider trades.
Insider Ownership Summary of Mikael Dolsten
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2015-03-31 | director |
| PFE | Pfizer Inc | 2022-05-11 | Senior Vice President |
| A | Agilent Technologies Inc | 2023-03-16 | director |
Mikael Dolsten Latest Holdings Summary
Mikael Dolsten currently owns a total of 1 stock. Mikael Dolsten owns 335,159 shares of Pfizer Inc (PFE) as of May 11, 2022, with a value of $9 Million.
Latest Holdings of Mikael Dolsten
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PFE | Pfizer Inc | 2022-05-11 | 335,159 | 25.40 | 8,513,039 |
Holding Weightings of Mikael Dolsten
Mikael Dolsten Form 4 Trading Tracker
According to the SEC Form 4 filings, Mikael Dolsten has made a total of 3 transactions in Pfizer Inc (PFE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Pfizer Inc is the sale of 63,902 shares on May 11, 2022, which brought Mikael Dolsten around $3 Million.
Insider Trading History of Mikael Dolsten
- 1
Mikael Dolsten Trading Performance
Mikael Dolsten Ownership Network
Ownership Network List of Mikael Dolsten
Ownership Network Relation of Mikael Dolsten
Mikael Dolsten Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Mikael Dolsten is the director of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include EVP & Chief Medical Officer Reshma Rangwala , director & President and CEO Richard A. Paulson , and EVP & CFO & Treasurer Michael Mason .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Mikael Dolsten made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 199,037 shares made by Richard A. Paulson , a net sale of 66,291 shares made by Michael Mason , and a net sale of 47,442 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 255,827 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 255,827 shares. During the past 18 months, 423,673 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 382,533 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Mikael Dolsten Mailing Address
Above is the net worth, insider trading, and ownership report for Mikael Dolsten. You might contact Mikael Dolsten via mailing address: 5 Giralda Farms, Madison Nj 07940.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
